GILD vs. BIIB
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Biogen Inc. (BIIB).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or BIIB.
Correlation
The correlation between GILD and BIIB is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GILD vs. BIIB - Performance Comparison
Loading data...
Key characteristics
GILD:
2.10
BIIB:
-1.60
GILD:
3.28
BIIB:
-2.42
GILD:
1.42
BIIB:
0.72
GILD:
2.12
BIIB:
-0.59
GILD:
11.94
BIIB:
-1.47
GILD:
5.27%
BIIB:
30.46%
GILD:
26.90%
BIIB:
28.46%
GILD:
-70.82%
BIIB:
-90.00%
GILD:
-13.00%
BIIB:
-74.12%
Fundamentals
GILD:
$129.26B
BIIB:
$18.23B
GILD:
$4.76
BIIB:
$10.12
GILD:
21.81
BIIB:
12.29
GILD:
0.20
BIIB:
6.24
GILD:
4.50
BIIB:
1.86
GILD:
6.30
BIIB:
1.02
GILD:
$28.73B
BIIB:
$9.70B
GILD:
$23.07B
BIIB:
$7.15B
GILD:
$9.89B
BIIB:
$2.15B
Returns By Period
In the year-to-date period, GILD achieves a 10.58% return, which is significantly higher than BIIB's -19.46% return. Over the past 10 years, GILD has outperformed BIIB with an annualized return of 2.73%, while BIIB has yielded a comparatively lower -10.94% annualized return.
GILD
10.58%
-2.12%
9.17%
55.82%
10.00%
2.73%
BIIB
-19.46%
6.94%
-26.81%
-45.34%
-17.23%
-10.94%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. BIIB — Risk-Adjusted Performance Rank
GILD
BIIB
GILD vs. BIIB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Biogen Inc. (BIIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
GILD vs. BIIB - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 3.06%, while BIIB has not paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 3.06% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
GILD vs. BIIB - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, smaller than the maximum BIIB drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for GILD and BIIB. For additional features, visit the drawdowns tool.
Loading data...
Volatility
GILD vs. BIIB - Volatility Comparison
Gilead Sciences, Inc. (GILD) has a higher volatility of 11.58% compared to Biogen Inc. (BIIB) at 9.57%. This indicates that GILD's price experiences larger fluctuations and is considered to be riskier than BIIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
GILD vs. BIIB - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Biogen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GILD vs. BIIB - Profitability Comparison
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a gross profit of 5.71B and revenue of 6.67B. Therefore, the gross margin over that period was 85.6%.
BIIB - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a gross profit of 1.80B and revenue of 2.43B. Therefore, the gross margin over that period was 74.1%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported an operating income of 3.15B and revenue of 6.67B, resulting in an operating margin of 47.2%.
BIIB - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported an operating income of 625.20M and revenue of 2.43B, resulting in an operating margin of 25.7%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.
BIIB - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Biogen Inc. reported a net income of 240.50M and revenue of 2.43B, resulting in a net margin of 9.9%.